semaglutide recent news Weight loss drug could boost heart health of up to 93M patients in US alone The recent approval by the

Indication: Once-daily oral semaglutide is indicated for adults with obesity (BMI 30 kg/m), or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, as an adjunct to reduced-calorie diet and increased physical activity

You should consider seeing an endocrinologist if you are struggling with weight loss despite lifestyle changes, or if you suspect your weight issues may be linked to a hormonal imbalance

But semaglutide (like similar drugs such as liraglutide and tirzepatide) is still under patent, meaning it is illegal to make a generic form

Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life

So we have one minute left, and I'm just wondering, what does it feel like to be a researcher who's been part of what's genuinely seen as a major breakthrough, almost like a once-in-a-generation kind of breakthrough for- so many diseases